Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valensa Granted Licenses for BiovaFlex Egg Shell Membrane - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Valensa Granted Licenses for BiovaFlex Egg Shell Membrane

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Valensa International Eustis, FL, has entered into a license agreement with Biova, LLC, Johnston, IA, which will allow Valensa to include the patented BiovaFlex water-soluble, egg shell membrane ingredient in a proprietary new series of formulated joint health products.

 
In addition, Valensa was granted a worldwide exclusive license for BiovaFlex in gummy-type chewables for joint health. In late 2009, Valensa announced that it had developed and filed provisional patents for a revolutionary range of joint, cardiovascular and eye healthcare dietary supplement and medical food formulations featuring Aker BioMarine krill oil and other condition-specific ingredients. The agreement with Biova is a continuation of Valensa’s program in the area of joint health. Valensa is currently discussing joint health formulations with select marketing partners and will announce commercial products in Q2 2010.

BiovaFlex is a proprietary, natural ingredient, rich in beneficial proteins such as elastin, collagens and glycosaminoglycans (chondroitin-sulfate, glucosamine and hyaluronic acid), designed to support the stability and flexibility of synovial joint functions.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics